Document is current
Any future updates will be listed below
-
Authors
Donders, Dominique N. V.
Heldens, Gijs T. N.
Tellman, Roosmarijn S.
Takes, Robert P.
van Bemmel, Alexander J. M.
de Visscher, Sebastiaan A. H. J.
Ghaeminia, Hossein
Alic, Lejla
Philippens, Marielle E. P.
Scheenen, Tom W. J.
de Keizer, Bart
de Bree, Remco
-
Funding
Funding for this research was provided by:
Dutch Cancer Society (14109)
- License Information
-
More Information
Article History
Received: 1 July 2025
Accepted: 14 August 2025
First Online: 9 October 2025
Declarations
:
: This research project obtained ethical approval from the Medical Research Ethics Committee Utrecht (NL81165.041.22, METC 22/637) on August 22, 2022. Only patients who have willingly signed the informed consent will be eligible for enrollment in this trial. Subsequent to receiving informed consent, each participating patient will be assigned a unique subject number, referred to as an allocation number. This allocated number will serve as the sole identifier for the patient throughout the course of the trial and within the study’s database. All data pertaining to the enrolled patients, gathered during the trial, will be securely stored under their respective allocation numbers.
: Not applicable.
: The authors declare no competing interests.
